IT201600109735A1 - Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla. - Google Patents

Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla.

Info

Publication number
IT201600109735A1
IT201600109735A1 IT102016000109735A IT201600109735A IT201600109735A1 IT 201600109735 A1 IT201600109735 A1 IT 201600109735A1 IT 102016000109735 A IT102016000109735 A IT 102016000109735A IT 201600109735 A IT201600109735 A IT 201600109735A IT 201600109735 A1 IT201600109735 A1 IT 201600109735A1
Authority
IT
Italy
Prior art keywords
biomarkers
methods
multiple sclerosis
vitro diagnosis
vitro
Prior art date
Application number
IT102016000109735A
Other languages
English (en)
Inventor
Giuseppe Lazzarino
Barbara Tavazzi
Giacomo Lazzarino
Angela Maria Amorini
Stasio Enrico Di
Claudio Gasperini
Original Assignee
Giuseppe Lazzarino
Barbara Tavazzi
Giacomo Lazzarino
Angela Maria Amorini
Stasio Enrico Di
Claudio Gasperini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuseppe Lazzarino, Barbara Tavazzi, Giacomo Lazzarino, Angela Maria Amorini, Stasio Enrico Di, Claudio Gasperini filed Critical Giuseppe Lazzarino
Priority to IT102016000109735A priority Critical patent/IT201600109735A1/it
Priority to PCT/IT2017/000238 priority patent/WO2018078665A1/en
Publication of IT201600109735A1 publication Critical patent/IT201600109735A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IT102016000109735A 2016-10-31 2016-10-31 Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla. IT201600109735A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102016000109735A IT201600109735A1 (it) 2016-10-31 2016-10-31 Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla.
PCT/IT2017/000238 WO2018078665A1 (en) 2016-10-31 2017-10-31 Biomarkers and methods for in vitro diagnosis of multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000109735A IT201600109735A1 (it) 2016-10-31 2016-10-31 Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla.

Publications (1)

Publication Number Publication Date
IT201600109735A1 true IT201600109735A1 (it) 2018-05-01

Family

ID=58163040

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000109735A IT201600109735A1 (it) 2016-10-31 2016-10-31 Biomarcatori e metodi per la diagnosi in vitro di sclerosi multipla.

Country Status (2)

Country Link
IT (1) IT201600109735A1 (it)
WO (1) WO2018078665A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7333942B2 (ja) * 2019-06-07 2023-08-28 株式会社スタージェン 神経変性疾患に対するａｔｐ増強療法の効果を予測する方法
CN116202939A (zh) * 2023-01-16 2023-06-02 中国科学技术大学 一种多发性硬化（ms）残疾程度的新型评价方法及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AMORINI A M ET AL: "Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients", CLINICAL BIOCHEMISTRY, ELSEVIER INC, US, CA, vol. 42, no. 10-11, 1 July 2009 (2009-07-01), pages 1001 - 1006, XP026173708, ISSN: 0009-9120, [retrieved on 20090331], DOI: 10.1016/J.CLINBIOCHEM.2009.03.020 *
AMORINI ANGELA M ET AL: "Serum lactate as a novel potential biomarker in multiple sclerosis", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, vol. 1842, no. 7, 2014, pages 1137 - 1143, XP028650680, ISSN: 0925-4439, DOI: 10.1016/J.BBADIS.2014.04.005 *
BARBARA TAVAZZI ET AL: "Serum Metabolic Profile in Multiple Sclerosis Patients", MULTIPLE SCLEROSIS INTERNATIONAL, vol. 2011, 1 January 2011 (2011-01-01), pages 1 - 8, XP055372543, ISSN: 2090-2654, DOI: 10.1155/2011/167156 *
GIACOMO LAZZARINO ET AL: "Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis", MOLECULAR NEUROBIOLOGY, 8 November 2016 (2016-11-08), US, XP055372547, ISSN: 0893-7648, DOI: 10.1007/s12035-016-0257-9 *

Also Published As

Publication number Publication date
WO2018078665A1 (en) 2018-05-03

Similar Documents

Publication Publication Date Title
IL257680A (en) Methods for diagnosing and evaluating non-alcoholic steatohepatitis
IL259747A (en) Antibodies targeting fc receptor-like 5 and methods of use
PL3543880T3 (pl) Układ do diagnozowania i rokowania w przypadku udaru mózgu
IL260678B (en) Systems and methods to improve diagnosis of diseases
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
EP3265588A4 (en) Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information
PT3295951T (pt) Anticorpos anti-pvrig e métodos de utilização
HUE045216T2 (hu) Anti-CD79B antitestek és alkalmazási eljárások
HUE054159T2 (hu) HPK1 gátlók és azok alkalmazási módja
DK3656875T3 (da) Ikke-invasiv prænatal diagnostik
EP3221340C0 (en) DIAGNOSTIC METHOD USING HUMAN NEUTROPHIL LIPOCALIN (HNL)
HUE048111T2 (hu) Anti-CEACAM6 ellenanyagok és alkalmazásuk
HUE055221T2 (hu) Tetrahidropiranil amino-pirrolopirimidinon és eljárások annak felhasználására
EP3411720C0 (en) METHODS OF DIAGNOSIS AND PROGNOSIS OF CARDIOVASCULAR DISEASES AND EVENTS
EP3232198A4 (en) Biomarker for diagnosis of hepatoma and use thereof
IL271257A (en) Multi-specific antibodies and methods of making and using thereof
PT3200582T (pt) Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress
IL252224B (en) Systems and methods for performing electrocardiograms
EP3157564C0 (en) ANTIBODY ANTAGONISTS OF ALPHA AND OMEGA INTERFERONS
HUE054093T2 (hu) Anti-HtrA1 antitestek és azok alkalmazási eljárásai
BR112017005252A2 (pt) método para detecção de molécula alvo e kit para utilização no referido método.
EP3510396A4 (en) DIAGNOSTIC SYSTEMS AND METHODS
HUE054864T2 (hu) In vitro módszer tüdõrák diagnosztizálására
ITUA20164448A1 (it) Metodo metagenomico per la diagnosi in vitro di disbiosi intestinale.
IL260301A (en) Compositions and methods for assessing the risk of cancer occurrence